Jiangzhong Pharmaceutical Co Ltd (600750) — Cash Flow Reinvestment Rate
Jiangzhong Pharmaceutical Co Ltd (600750) has a Cash Flow Reinvestment Rate of 0.29x as of September 2025, reinvesting CN¥95.46 Million (capex CN¥95.46 Million ) from operating cash flow of CN¥326.81 Million. See Jiangzhong Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangzhong Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Jiangzhong Pharmaceutical Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see Jiangzhong Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Jiangzhong Pharmaceutical Co Ltd (2000–2025)
Year-by-year capital reinvestment analysis for Jiangzhong Pharmaceutical Co Ltd. See how financially flexible is Jiangzhong Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥377.57 Million | CN¥970.87 Million | CN¥280.57 Million | ▼ -49.0% |
| 2024 | 0.76x | CN¥599.39 Million | CN¥786.25 Million | CN¥290.77 Million | ▲ +135.1% |
| 2023 | 0.32x | CN¥335.91 Million | CN¥1.04 Billion | CN¥208.88 Million | ▼ -53.8% |
| 2022 | 0.70x | CN¥716.51 Million | CN¥1.02 Billion | CN¥345.64 Million | ▼ -57.0% |
| 2021 | 1.63x | CN¥1.50 Billion | CN¥917.04 Million | CN¥188.49 Million | ▲ +78.3% |
| 2020 | 0.92x | CN¥688.96 Million | CN¥752.50 Million | CN¥182.53 Million | ▼ -12.0% |
| 2019 | 1.04x | CN¥666.99 Million | CN¥641.18 Million | CN¥76.33 Million | ▲ +206.4% |
| 2018 | 0.34x | CN¥165.10 Million | CN¥486.25 Million | CN¥121.38 Million | ▼ -80.8% |
| 2017 | 1.77x | CN¥221.21 Million | CN¥124.93 Million | CN¥181.21 Million | ▲ +1582.0% |
| 2016 | 0.11x | CN¥73.49 Million | CN¥698.05 Million | CN¥70.07 Million | ▼ -69.7% |
| 2015 | 0.35x | CN¥177.25 Million | CN¥510.78 Million | CN¥62.75 Million | ▲ +21.0% |
| 2014 | 0.29x | CN¥102.33 Million | CN¥356.80 Million | CN¥102.33 Million | ▼ -50.3% |
| 2013 | 0.58x | CN¥64.59 Million | CN¥111.92 Million | CN¥64.59 Million | ▼ -41.8% |
| 2012 | 0.99x | CN¥224.42 Million | CN¥226.38 Million | CN¥224.42 Million | ▼ -32.6% |
| 2011 | 1.47x | CN¥247.55 Million | CN¥168.30 Million | CN¥247.55 Million | ▲ +132.1% |
| 2010 | 0.63x | CN¥140.86 Million | CN¥222.29 Million | CN¥140.86 Million | ▲ +1138.0% |
| 2009 | 0.05x | CN¥19.37 Million | CN¥378.32 Million | CN¥19.37 Million | ▼ -32.8% |
| 2008 | 0.08x | CN¥20.49 Million | CN¥268.87 Million | CN¥20.49 Million | ▲ +4.9% |
| 2007 | 0.07x | CN¥11.16 Million | CN¥153.63 Million | CN¥11.16 Million | ▼ -86.9% |
| 2006 | 0.56x | CN¥30.69 Million | CN¥55.24 Million | CN¥30.69 Million | ▲ +68.5% |
| 2005 | 0.33x | CN¥65.42 Million | CN¥198.45 Million | CN¥65.42 Million | ▼ -96.7% |
| 2004 | 10.01x | CN¥263.03 Million | CN¥26.28 Million | CN¥263.03 Million | ▲ +241.5% |
| 2003 | 2.93x | CN¥231.42 Million | CN¥78.98 Million | CN¥231.42 Million | ▲ +141.0% |
| 2002 | 1.22x | CN¥115.40 Million | CN¥94.90 Million | CN¥115.40 Million | ▲ +892.2% |
| 2001 | 0.12x | CN¥5.06 Million | CN¥41.28 Million | CN¥5.06 Million | ▼ -45.2% |
| 2000 | 0.22x | CN¥27.22 Million | CN¥121.77 Million | CN¥27.22 Million | — |